AU5103396A - Method for the diagnosis of injections - Google Patents

Method for the diagnosis of injections

Info

Publication number
AU5103396A
AU5103396A AU51033/96A AU5103396A AU5103396A AU 5103396 A AU5103396 A AU 5103396A AU 51033/96 A AU51033/96 A AU 51033/96A AU 5103396 A AU5103396 A AU 5103396A AU 5103396 A AU5103396 A AU 5103396A
Authority
AU
Australia
Prior art keywords
injections
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51033/96A
Inventor
Klaus Hedman
Maria Soderlund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU5103396A publication Critical patent/AU5103396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14211—Erythrovirus, e.g. B19 virus
    • C12N2750/14222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/015—Parvoviridae, e.g. feline panleukopenia virus, human Parvovirus
AU51033/96A 1995-03-08 1996-03-07 Method for the diagnosis of injections Abandoned AU5103396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95103356 1995-03-08
EP95103356 1995-03-08
PCT/EP1996/000979 WO1996027799A1 (en) 1995-03-08 1996-03-07 Method for the diagnosis of infections

Publications (1)

Publication Number Publication Date
AU5103396A true AU5103396A (en) 1996-09-23

Family

ID=8219051

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51033/96A Abandoned AU5103396A (en) 1995-03-08 1996-03-07 Method for the diagnosis of injections

Country Status (3)

Country Link
EP (1) EP0813683A1 (en)
AU (1) AU5103396A (en)
WO (1) WO1996027799A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2456715A1 (en) 2001-08-31 2003-03-13 Gen-Probe Incorporated Assay for detection of human parvovirus b19 nucleic acid
CA2756659A1 (en) 2009-02-26 2010-09-02 Gen-Probe Incorporated Assay for detection of human parvovirus nucleic acid
CA2841531C (en) 2011-07-15 2021-11-09 Gen-Probe Incorporated Compositions and method for detecting human parvovirus nucleic acid and for detecting hepatitis a virus nucleic acids in single-plex or multiplex assays

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8902301A (en) * 1989-09-14 1991-04-02 Rijksuniversiteit HUMAN PARVOVIRUS B19 PROTEINS, THEIR PRODUCTION AND THEIR USE IN DIAGNOSTIC ASSAYS AND VACCINES.
DE4003826C2 (en) * 1990-02-08 1995-11-23 Mikrogen Molekularbiol Entw Peptides of the capsid proteins VP1 or VP2 of the parvovirus B19
JPH06293798A (en) * 1993-04-06 1994-10-21 Shin Etsu Chem Co Ltd Epitope-related peptide of human parvovirus b19

Also Published As

Publication number Publication date
EP0813683A1 (en) 1997-12-29
WO1996027799A1 (en) 1996-09-12

Similar Documents

Publication Publication Date Title
AU696462B2 (en) Diagnostic method
AU1771195A (en) Method of administering azithromycin
AU7317396A (en) Diagnostic apparatus
AU1055797A (en) Surgical fastening system and method for using the same
EP0637630A3 (en) Method for the biological synthesis of peptides
AU6490396A (en) Substituted-pent-4-ynoic acids
AU6384596A (en) An improved electrochemiluminescence method
AU2734895A (en) Process for the preparation of 3-aryluracils
EP0736761A3 (en) Engine diagnostic monitor
AU5486596A (en) Surgical method
AU1865497A (en) Method for the treatment of a liquid
AU7096496A (en) Process for the preparation of 4-methylenepiperidines
AU5486396A (en) Process for the preparation of spiroindolines
AU7823694A (en) Imaging method
AU6597396A (en) Novel 3-amido-triiodophenyl esters as x-ray contrast agents
AU7347694A (en) Diagnostic method
AU5103396A (en) Method for the diagnosis of injections
AU7506896A (en) Method for the simultaneous detection of polygenes
AUPN058895A0 (en) Diagnostic method
AU4670696A (en) Diagnosis of toxicoinfectious clostridiosis
AU3706395A (en) Assay method for catheter related sepsis
AUPN192695A0 (en) Diagnosis method
AU5298096A (en) Procedures for obtaining ribo-c-nucleosides
AU7004096A (en) Syringe
AU7290096A (en) Substituted benzylidenecyanoacetic esters